Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice

References

• Abbaspanah B, Reyhani S, Mousavi SH. 2021. Applications of umbilical cord derived mesenchymal stem cells in autoimmune and immunological disorders: from literature to clinical practice. Curr Stem Cell Res Ther. 16(4):454–64.
   PubMed Web of Science ®Google Scholar
• Ahmadvand Koohsari S, Absalan A, Azadi D. 2021. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles attenuate experimental autoimmune encephalomyelitis via regulating pro and anti-inflammatory cytokines. Sci Rep. 11(1):11658.
   PubMed Web of Science ®Google Scholar
• Akcay A, Atay D, Erbey F, Akinci B, Demir Yenigurbuz F, Eyuboglu F, Ovali E, Ozturk G. 2021. Safety and efficacy of co-transplantation of hematopoietic stem cells combined with human umbilical cord-derived mesenchymal stem cells in children with severe aplastic anemia: a single-center experience. Exp Clin Transplant. doi:10.6002/ect.2021.0027
   Google Scholar
• Aldrich ED, Cui X, Murphy CA, Lim KS, Hooper GJ, McIlwraith CW, Woodfield TBF. 2021. Allogeneic mesenchymal stromal cells for cartilage regeneration: a review of in vitro evaluation, clinical experience, and translational opportunities. Stem Cells Transl Med. 10:1500–15.
   PubMed Web of Science ®Google Scholar
• Arabpour M, Saghazadeh A, Rezaei N. 2021. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes. Int Immunopharmacol. 97:97107823.
   Web of Science ®Google Scholar
• Barbado J, Tabera S, Sanchez A, Garcia-Sancho J. 2018. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 27(13):2161–65.
   PubMed Web of Science ®Google Scholar
• Barreto M, Ferreira RC, Lourenco L, Moraes-Fontes MF, Santos E, Alves M, Carvalho C, Martins B, Andreia R, Viana JF, et al. 2009. Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants. BMC Immunol. 10(5).
   PubMedGoogle Scholar
• Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med. 189(10):1639–48.
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Morishita M, Matsumoto A, Nishikawa M, Takakura Y. 2017. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci. 96: 316–22.
   PubMed Web of Science ®Google Scholar
• Chen T, Cao Q, Wang Y, Harris DCH. 2019. M2 macrophages in kidney disease: biology, therapies, and perspectives. Kidney Int. 95(4):760–73.
   PubMed Web of Science ®Google Scholar
• Chen X, Wei Q, Sun H, Zhang X, Yang C, Tao Y, Nong G. 2021. Exosomes derived from human umbilical cord mesenchymal stem cells regulate macrophage polarization to attenuate systemic lupus erythematosus-associated diffuse alveolar hemorrhage in mice. Int J Stem Cells. 14:331–40.
   PubMed Web of Science ®Google Scholar
• Contreras-Lopez R, Elizondo-Vega R, Paredes MJ, Luque-Campos N, Torres MJ, Tejedor G, Vega-Letter AM, Figueroa-Valdes A, Pradenas C, Oyarce K, et al. 2020. HIF1alpha-dependent metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions. FASEB J. 34(6):8250–64.
   PubMed Web of Science ®Google Scholar
• Darlan DM, Munir D, Putra A, Jusuf NK. 2021. MSCs-released TGFbeta1 generate CD4(+)CD25(+)Foxp3(+) in T-reg cells of human SLE PBMC. J Formos Med Assoc. 120(1 Pt 3):602–08.
   PubMed Web of Science ®Google Scholar
• Dong B, Wang C, Zhang J, Zhang J, Gu Y, Guo X, Zuo X, Pan H, Hsu AC, Wang G, et al. 2021. Exosomes from human umbilical cord mesenchymal stem cells attenuate the inflammation of severe steroid-resistant asthma by reshaping macrophage polarization. Stem Cell Res Ther. 12(1):204.
   PubMed Web of Science ®Google Scholar
• El-Jawhari JJ, El-Sherbiny Y, McGonagle D, Jones E. 2021. Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Front Immunol. 12:643170.
   PubMed Web of Science ®Google Scholar
• Funes SC, Rios M, Escobar-Vera J, Kalergis AM. 2018. Implications of macrophage polarization in autoimmunity. Immunology. 154(2):186–95.
   PubMed Web of Science ®Google Scholar
• Geng L, Tang X, Wang S, Sun Y, Wang D, Tsao BP, Feng X, Sun L. 2020. Reduced let-7f in bone marrow-derived mesenchymal stem cells triggers Treg/Th17 imbalance in patients with systemic lupus erythematosus. Front Immunol. 11:233.
   PubMed Web of Science ®Google Scholar
• Heidari N, Abbasi-Kenarsari H, Namaki S, Baghaei K, Zali MR, Ghaffari Khaligh S, Hashemi SM. 2021. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction. J Cell Physiol. 236(8):5906–20.
   PubMed Web of Science ®Google Scholar
• Hoseinnia S, Ghane M, Norouzi J, Hosseini F. 2021. Mesenchymal stem cell and endothelial progenitor cells coinjection improves LPS-induced lung injury via Tie2 activation and downregulation of the TLR4/MyD88 pathway. J Cell Biochem. 122:1791–804.
   PubMed Web of Science ®Google Scholar
• Imai T, Takahashi Y, Nishikawa M, Kato K, Morishita M, Yamashita T, Matsumoto A, Charoenviriyakul C, Takakura Y. 2015. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 426238.
   Google Scholar
• Jin X, Hou J, Zheng K, Wei D, Zhang A, Wang S, Mei H, Li C, Cheng L, Sun X. 2021. Umbilical cord mesenchymal stem cells for inhibiting the fibrosis and autoimmune development in HOCl-induced systemic scleroderma mouse model. Int J Stem Cells. 14:262–74.
   PubMed Web of Science ®Google Scholar
• Jing C, Castro-Dopico T, Richoz N, Tuong ZK, Ferdinand JR, Lok LSC, Loudon KW, Banham GD, Mathews RJ, Cader Z, et al. 2020. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc Natl Acad Sci USA. 117(26):15160–71.
   PubMed Web of Science ®Google Scholar
• Kahmini FR, Shahgaldi S. 2021. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders. Exp Mol Pathol. 118: 104566.
   PubMed Web of Science ®Google Scholar
• Kavianpour M, Saleh M, Verdi J. 2020. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm. Stem Cell Res Ther. 11(1):404.
   PubMed Web of Science ®Google Scholar
• Kikawada E, Lenda DM, Kelley VR. 2003. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol. 170(7):3915–25.
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig AK, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. 2014. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 28(4):970–73.
   PubMed Web of Science ®Google Scholar
• Kouroupis D, Lanzoni G, Linetsky E, Messinger Cayetano S, Wishnek Metalonis S, Lenero C, Stone LD, Ruiz P, Correa D, Ricordi C. 2021. Umbilical cord-derived mesenchymal stem cells modulate TNF and soluble TNF receptor 2 (sTNFR2) in COVID-19 ARDS patients. Eur Rev Med Pharmacol Sci. 25(12):4435–38.
   PubMed Web of Science ®Google Scholar
• La Cava A. 2013. Targeting the BLyS-April signaling pathway in SLE. Clin Immunol. 148(3):322–27.
   PubMed Web of Science ®Google Scholar
• Li W, Chen W, Sun L. 2021b. An update for mesenchymal stem cell therapy in lupus nephritis. Kidney Dis (Basel). 7(2):79–89.
   PubMed Web of Science ®Google Scholar
• Li F, Yang Y, Zhu X, Huang L, Xu J. 2015. Macrophage polarization modulates development of systemic lupus erythematosus. Cell Physiol Biochem. 37(4):1279–88.
   PubMedGoogle Scholar
• Li M, Yu D, Wang Y, Luo N, Han G, Yang B. 2021a. Interferon-alpha activates interleukin-1 receptor-associated kinase 1 to induce regulatory T-cell apoptosis in patients with systemic lupus erythematosus. J Dermatol. 48:1172–85.
   PubMed Web of Science ®Google Scholar
• Lin F, Ichim TE, Pingle S, Jones LD, Kesari S, Ashili S. 2020. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. World J Stem Cells. 12(10):1067–79.
   PubMed Web of Science ®Google Scholar
• Luo Y, Guo J, Zhang P, Cheuk YC, Jiang Y, Wang J, Xu S, Rong R. 2021. Mesenchymal stem cell protects injured renal tubular epithelial cells by regulating mTOR-mediated Th17/Treg axis. Front Immunol. 12:684197.
   PubMed Web of Science ®Google Scholar
• Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. 2021. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther. 12(1):192.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Memarian A, Sedighi S, Behnampour N, Yazdani Y. 2018a. Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: a crucial role for aryl hydrocarbon receptor. Autoimmunity. 51(5):199–209.
   PubMed Web of Science ®Google Scholar
• Mohammadi S, Saghaeian-Jazi M, Sedighi S, Memarian A. 2018b. Sodium valproate modulates immune response by alternative activation of monocyte-derived macrophages in systemic lupus erythematosus. Clin Rheumatol. 37(3):719–27.
   PubMed Web of Science ®Google Scholar
• Naserian S, Shamdani S, Arouche N, Uzan G. 2020. Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells. Stem Cell Res Ther. 11(1):534.
   PubMed Web of Science ®Google Scholar
• O Ercelen N, Pekkoc-Uyanik KC, Alpaydin N, Gulay GR, Simsek M. 2021. Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey. Stem Cell Rev Rep. 17:1917–25.
   PubMed Web of Science ®Google Scholar
• Okamoto T. 2006. NF-kappaB and rheumatic diseases. Endocr Metab Immune Disord Drug Targets. 6(4):359–72.
   PubMedGoogle Scholar
• Peixoto TV, Carrasco S, Botte DAC, Catanozi S, Parra ER, Lima TM, Ugriumov N, Soriano FG, de Mello SBV, Rodrigues CM, et al. 2019. CD4(+)CD69(+) T cells and CD4(+)CD25(+)FoxP3(+) Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice. Adv Rheumatol. 59(1):30.
   PubMedGoogle Scholar
• Scherlinger M, Guillotin V, Douchet I, Vacher P, Boizard-Moracchini A, Guegan JP, Garreau A, Merillon N, Vermorel A, Ribeiro E, et al. 2021. Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis. Sci Transl Med. 13(600):eabi4994.
   PubMed Web of Science ®Google Scholar
• Schnatz A, Muller C, Brahmer A, Kramer-Albers EM. 2021. Extracellular vesicles in neural cell interaction and CNS homeostasis. FASEB Bioadv. 3(8):577–92.
   PubMedGoogle Scholar
• Seo Y, Kang MJ, Kim HS. 2021. Strategies to potentiate paracrine therapeutic efficacy of mesenchymal stem cells in inflammatory diseases. Int J Mol Sci. 22(7):3397.
   PubMed Web of Science ®Google Scholar
• Shan J, Jin H, Xu Y. 2020. T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus. Front Immunol. 11:1027.
   PubMed Web of Science ®Google Scholar
• Tang X, Li W, Wen X, Zhang Z, Chen W, Yao G, Chen H, Wang D, Shi S, Sun L. 2019. Transplantation of dental tissue-derived mesenchymal stem cells ameliorates nephritis in lupus mice. Ann Transl Med. 7(7):132.
   PubMed Web of Science ®Google Scholar
• Thakur A, Ke X, Chen YW, Motallebnejad P, Zhang K, Lian Q, Chen HJ. 2021. The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics. Protein Cell. doi:10.1007/s13238-021-00863-6
   PubMed Web of Science ®Google Scholar
• Tsokos GC. 2011. Systemic lupus erythematosus. N Engl J Med. 365(22):2110–21.
   PubMed Web of Science ®Google Scholar
• Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L. 2017. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 14(5):423–31.
   PubMed Web of Science ®Google Scholar
• Wang JH, Liu XL, Sun JM, Yang JH, Xu DH, Yan SS. 2020. Role of mesenchymal stem cell derived extracellular vesicles in autoimmunity: a systematic review. World J Stem Cells. 12(8):879–96.
   PubMed Web of Science ®Google Scholar
• Wang Q, Qian S, Li J, Che N, Gu L, Wang Q, Liu Y, Mei H. 2015. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia. Lupus. 24(11):1221–26.
   PubMed Web of Science ®Google Scholar
• Wei Z, Yuan J, Wang G, Ocansey DKW, Xu Z, Mao F. 2021. Regulatory effect of mesenchymal stem cells on T cell phenotypes in autoimmune diseases. Stem Cells Int. 2021:5583994.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Van Balkom BWM, Bruno S, Choo A, Dominici M, Gimona M, Hill AF, De Kleijn D, Koh M, Lai RC, et al. 2019. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 8(1):1609206.
   PubMed Web of Science ®Google Scholar
• Xu K, Ma D, Zhang G, Gao J, Su Y, Liu S, Liu Y, Han J, Tian M, Wei C, et al. 2021. Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes. Mol Immunol. 135:36–44.
   PubMed Web of Science ®Google Scholar
• Yang JH, Liu FX, Wang JH, Cheng M, Wang SF, Xu DH. 2020. Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: potential roles in rheumatic diseases. World J Stem Cells. 12(7):688–705.
   PubMed Web of Science ®Google Scholar
• Yang C, Wu M, You M, Chen Y, Luo M, Chen Q. 2021. The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther. 12(1):103.
   PubMed Web of Science ®Google Scholar
• Yuan X, Qin X, Wang D, Zhang Z, Tang X, Gao X, Chen W, Sun L. 2019. Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients. Nat Commun. 10(1):2498.
   PubMedGoogle Scholar
• Zheng Q, Zhang S, Guo WZ, Li XK. 2021. The unique immunomodulatory properties of MSC-derived exosomes in organ transplantation. Front Immunol. 12:659621.
   PubMed Web of Science ®Google Scholar
• Zong L, Huang P, Song Q, Kang Y. 2021. Bone marrow mesenchymal stem cells-secreted exosomal H19 modulates lipopolysaccharides-stimulated microglial M1/M2 polarization and alleviates inflammation-mediated neurotoxicity. Am J Transl Res. 13(3):935–51.
   PubMed Web of Science ®Google Scholar